Name: UMIN ID:
Unique ID issued by UMIN | C000000197 |
---|---|
Receipt number | R000000266 |
Scientific Title | Efficasy of combination therapy PEG-IFN-alpha-2b and Ribavirin for patients with Serogroup1 and high titer HCV. |
Date of disclosure of the study information | 2008/12/31 |
Last modified on | 2020/03/25 22:13:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/13 02:50:14 | ||
2 | Update | 2016/09/30 15:42:54 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person Address TEL Name of person sending information Name of person sending information Organization Division name Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2016/09/30 15:45:30 | UMIN ID1 |
|
4 | Update | 2016/09/30 15:48:58 | Last follow-up date |
|
5 | Update | 2018/07/31 21:55:29 | Recruitment status |
|
6 | Update | 2019/08/02 14:52:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
7 | Update | 2020/03/25 22:13:08 | Email |